Clinical Trials on Urethritis in Czechia

Total 352 results

AB Science

Terminated

Masitinib in Refractory Active Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Czechia
Rottapharm Biotech

Completed

A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis

Rheumatoid Arthritis, DMARD-naive and Early Disease Patients

Czechia
Italfarmaco
Parexel

Terminated

Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

Czechia
Pfizer

Completed

Changes of Depression After First-year of Tofacitinib in RA Patients

Rheumatoid Arthritis

Czechia
Fidia Farmaceutici s.p.a.

Completed

A Multicentre Clinical Investigation to Assess Efficacy and Safety of Intra-articular Injections of Hyaluronic Acid Combined With Chondroitin Sulfate in Knee Osteoarthritis

Osteo Arthritis Knee

Czechia
Anika Therapeutics, Inc.

Completed

MONOVISC for Shoulder Joint Pain Relief

Osteo Arthritis Shoulders

Poland, Czechia
Ablynx

Completed

Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Poland, Hungary, Czechia
Aesculap AG

Recruiting

Ceramic Modular Dual Mobility in Primary Total Hip Arthroplasty (THA) (CeMoD-prime)

Coxarthrosis; Primary

Czechia
Medical University of Vienna

Completed

A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

Rheumatoid Arthritis

Austria, Czechia, Russian Federation, Switzerland
TcLand Expression S.A.
European Commission

Terminated

RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis (RABIOPRED)

RheumatoId Arthritis

France, Netherlands, Turkey, Czechia, Israel
Frederiksberg University Hospital

Withdrawn

ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid | Telerehabilitation

Denmark, Czechia, United Kingdom
Sanofi

Completed

Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis (ACCORD-RA)

Rheumatoid Arthritis

Romania, Russian Federation, Ukraine, Bulgaria, Slovakia, Croatia, Czechia
Anika Therapeutics, Inc.

Completed

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint

Osteoarthritis, Hip

Czechia, Poland
Anika Therapeutics, Inc.

Completed

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Ankle Joint

Osteoarthritis, Ankle

Czechia, Poland
Anika Therapeutics, Inc.

Completed

Study of Cingal® for Symptomatic Relief of Osteoarthritis of Shoulder Joint

Osteoarthritis, Shoulder

Czechia, Poland
Allergan

Completed

BOTOX® Efficacy and Safety in the Treatment of Knee Osteoarthritis

Osteoarthritis

Czechia, United States, Denmark
Anika Therapeutics, Inc.

Completed

MONOVISC for Hip Joint Pain Relief

Osteoarthritis, Hip

Poland, Czechia
Anika Therapeutics, Inc.

Completed

MONOVISC for Ankle Joint Pain Relief

Osteoarthritis Ankle

Poland, Czechia
Faculty Hospital Kralovske Vinohrady

Completed

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Infections | Multiple Sclerosis | Autoimmune Diseases | Diabetes Mellitus, Type 1 | Rheumatoid Arthritis | Vaccine Reaction | Inflammatory Bowel Diseases | Psoriasis | Crohn Disease | Ulcerative Colitis | Down Syndrome | Atopic Dermatitis | Vitiligo | Alopecia Areata | COVID-19 Pandemic | Ankylosing Spondylitis | Lupus Erythematosus and other conditions

Czechia
Teva Pharmaceutical Industries, Ltd.

Completed

TL011 in Severe, Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Czechia, Hungary, Italy, Spain, United Kingdom
Sanofi
Regeneron Pharmaceuticals

Terminated

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

Rheumatoid Arthritis

United States, Italy, Mexico, Colombia, Czechia, Spain
UCB Celltech
PRA Health Sciences

Completed

Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Czechia, Hungary, Moldova, Republic of, Poland, Russian Federation, Slovakia, United Kingdom
Gilead Sciences

Completed

Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary, Czech Republic
Novartis Pharmaceuticals

Active, not recruiting

A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)

Knee Osteoarthritis

United States, Hungary, Estonia, Poland, Czechia, Latvia
Anika Therapeutics, Inc.

Completed

Repeat Injection of Cingal® for Osteoarthritis of the Knee

Osteoarthritis of the Knee

Czechia, Hungary, Poland
Takeda

Terminated

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate (TELLUS)

Rheumatoid Arthritis

Spain, Estonia, Russian Federation, Czechia, United Kingdom
Eupraxia Pharmaceuticals Inc.
NBCD A/S

Completed

Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee

Osteoarthritis, Knee

Poland, Czechia, Denmark
Abivax S.A.

Completed

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, France, Czechia, Hungary, Poland
Abivax S.A.

Completed

Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, France, Czechia, Hungary, Poland
Amzell

Completed

AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Osteoarthritis, Knee

United States, Czechia, Denmark
Nordic Bioscience A/S
Novartis

Completed

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis

Osteoarthritis

Denmark, Estonia, Hong Kong, Poland, Romania, Czechia
Galapagos NV

Completed

A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis (EQUATOR)

Psoriatic Arthritis

Estonia, Belgium, Bulgaria, Czechia, Poland, Spain, Ukraine
Can-Fite BioPharma

Completed

Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Israel, Czechia, Bulgaria, Poland, Serbia, Ukraine
AbbVie (prior sponsor, Abbott)

Completed

Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

Rheumatoid Arthritis

Belgium, Czech Republic
Levicept
Nordic Bioscience Clinical Development (NBCD)

Active, not recruiting

Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

Pain | Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Knee Osteoarthritis | Osteo Arthritis Knee

Poland, Czechia, Denmark, Hong Kong, Moldova, Republic of
Galapagos NV

Terminated

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

Psoriatic Arthritis

Estonia, Belgium, Bulgaria, Czechia, Poland, Spain, Ukraine
Gilead Sciences

Completed

Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate

Rheumatoid Arthritis

United States, Czechia, Bulgaria, Poland, Georgia, Moldova, Republic of, Ukraine
Chong Kun Dang Pharmaceutical

Completed

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Rheumatoid Arthritis

Czechia, Georgia, Poland, Russian Federation, Ukraine
Novartis Pharmaceuticals

Completed

Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis.

Osteoarthritis

United States, Denmark, Czechia
Pfizer

Completed

Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

Rheumatoid Arthritis

United States, Poland, Serbia, Slovakia, Czechia, Georgia, Germany, Bulgaria, Hungary
ACELYRIN Inc.

Completed

A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis

Psoriatic Arthritis

Poland, Hungary, Germany, Belgium, Czechia, Austria, Spain
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Moderate to Severe Rheumatoid Arthritis (Auriel-RA)

Moderate to Severe Rheumatoid Arthritis

Bulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
JHL Biotech, Inc.

Terminated

A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis

Arthritis, Rheumatoid | Rheumatoid Arthritis

Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Lithuania, Poland, Russian Federation, Taiwan, Ukraine, United Kingdom
Novartis Pharmaceuticals

Completed

Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) (PDUS)

Psoriatic Arthritis

Germany, Netherlands, Spain, Argentina, Belgium, Colombia, Italy, United States, United Kingdom, Ireland, France, Mexico, Canada, Austria, Czechia, Hungary, Norway
Sanofi

Completed

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis (LEADER)

Arthritis, Rheumatoid

Romania, Portugal, Czech Republic, Italy, Korea, Republic of
EMD Serono Research & Development Institute, Inc.
Nordic Bioscience A/S

Completed

A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee (FORWARD)

Osteoarthritis, Knee

Estonia, Romania, Hong Kong, Czechia, Denmark, Poland, Argentina, United States
Italfarmaco

Terminated

Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis

Polyarticular Course Juvenile Idiopathic Arthritis

Belgium, Spain, Serbia, Czech Republic, Italy, Romania, Slovenia
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA) (SARIL-RA-ONE)

Rheumatoid Arthritis

United States, Chile, Czechia, Estonia, Hungary, Poland, Russian Federation
DePuy International

Terminated

A Single Centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Ceramic-on-ceramic Bearing in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral Fractures

Czech Republic
Modern Biosciences Ltd

Completed

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Rheumatoid Arthritis

Bosnia and Herzegovina, Bulgaria, Chile, Czechia, Guatemala, Mexico, Poland, Serbia

Clinical Trials on Urethritis in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations